Tag - japan-medicine

 
 

JAPAN MEDICINE

A woman receives a COVID-19 vaccine in Minato Ward, Tokyo, in October.
JAPAN / Science & Health
Dec 29, 2024
Meiji Seika Pharma files suit against lawmaker over 'unfounded' vaccine claims
CDP Lower House lawmaker Kazuhiro Haraguchi has said that the drugmaker's replicon vaccine is "akin to a biological weapon."
A man receives a COVID-19 vaccine in Tokyo on Oct. 1. Experts say fears over the newly approved replicon vaccine are unwarranted.
JAPAN / Science & Health
Oct 7, 2024
Experts move to allay replicon COVID shot fears in Japan amid backlash
The health ministry and experts say concerns around "shedding" are unwarranted.
People hold umbrellas while watching baseball to deal with the heat in the city of Shizuoka on July 7.
JAPAN / Science & Health
Jul 19, 2024
As risk of heatstroke rises in Japan, so does that of COVID-19
Patients examined for suspected heatstroke have been diagnosed with COVID-19 instead, as symptoms can be similar.
Japan Times
JAPAN
May 7, 2023
Cumulative COVID-19 cases in Japan reach 33.8 million
The number of COVID-19 cases in Japan reached 33,812,143 on Sunday, meaning that more than one-fourth of the country's population has been infected since the outbreak about three years ago.
JAPAN
May 7, 2023
Japan steps into post-pandemic phase with scrapping of COVID measures
The move will have a far-reaching impact on the nation’s health care system and beyond, affecting everything from the cost of treatment to the reporting of COVID cases.
JAPAN
Mar 10, 2023
Government to scale back COVID support with disease downgrade on May 8
The move means much of the state subsidies for screening and treatments will be scaled back and free COVID testing and outpatient care will end.
Japan Times
BUSINESS / Companies
Feb 27, 2023
Shionogi sees COVID pill reaping $2 billion in annual sales upon U.S. approval
CEO Isao Teshirogi said he expects U.S. approval of the drug could come by the winter of 2024, pending a late-stage trial.
JAPAN / Science & Health
Feb 22, 2023
Shionogi says its drug Xocova may reduce risks of long COVID symptoms
For 14 major symptoms of COVID-19, 14.5% of those given Xocova reported at least one of the symptoms six months after the start of treatment, compared with 26.3% who were given a placebo.
JAPAN / Politics
Feb 7, 2023
Japan's government adopts bills to prepare for future pandemics
The government will also establish an infectious disease crisis management agency at the Cabinet Secretariat possibly in fall this year.
Japan Times
JAPAN
Jan 13, 2023
Hospital given COVID-19 aid refused to accept patient, Japan auditor says
In response to the board's inquiry, one hospital explained that it had to refuse a patient for a bed because of a shortage of nurses.
JAPAN / Science & Health
Dec 15, 2022
Despite unclear effectiveness, kanpō in short supply amid COVID wave
The widespread use and availability of kanpu014d in Japan has given some people hope that it may work as a viable treatment for the viral disease.
JAPAN / Science & Health
Dec 13, 2022
Shionogi says Japan government to buy 1 million more COVID pill doses
The added supply agreement comes at a time when Japan is dealing with an eighth wave of COVID-19 infections.
JAPAN
Oct 13, 2022
Japan updates advice on clinic visits for COVID patients amid 'twindemic' fears
People between the ages of 12 and 64 with a low risk of developing severe COVID-19 symptoms have been asked to refrain from going to so-called fever clinics.
JAPAN / Science & Health
Oct 2, 2022
Kowa says ivermectin not effective in treating COVID-19
The Nagoya-based company announced the results of its clinical trial, indicating it would no longer seek the drug's approval for COVID-19 treatment.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Shionogi says COVID-19 pill trial shows reduction in symptoms
The drug met the trial's goal of reducing five key symptoms of the omicron variant within 72 hours of onset, the company said.

Longform

Sumadori Bar on Shibuya Ward's main Center Gai street targets young customers who prefer low-alcohol drinks or abstain altogether.
Rethinking that second drink: Japan’s Gen Z gets ‘sober curious’